{
  "id": 102,
  "text": "# 5.6.2 Management of patients with pT1a1, LVSI $\\pm$ and pT1a2 LVSI-negative, with clear margins In patients with tumor stage pT1a1 regardless of LVSI status and pT1a2 LVSI negative with clear margins in the hysterectomy specimen, no additional treatment is recommended.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # 5.6.2 Management of patients with pT1a1, LVSI $\\pm$ and pT1a2 LVSI-negative, with clear margins In patients with tumor stage pT1a1 regardless of LVSI status and pT1a2 LVSI negative with clear margins in the hysterectomy specimen, no additional treatment is recommended.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于宫颈癌患者，若肿瘤分期为pT1a1，无论是否存在淋巴血管空间侵犯（LVSI），以及分期为pT1a2且淋巴血管空间侵犯为阴性且切缘清晰的情况下，并不建议进行进一步的治疗。这意味着，手术切除后的这些早期宫颈癌患者在上述特定情况下无需接受额外的治疗。",
  "query": "对于宫颈癌患者，手术切除后肿瘤分期为pT1a1并且无论是否存在淋巴血管空间侵犯（LVSI），以及pT1a2淋巴血管空间侵犯阴性且切缘清晰的情况下，是否建议进行进一步治疗？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于宫颈癌患者，手术切除后肿瘤分期为pT1a1并且无论是否存在淋巴血管空间侵犯（LVSI），以及pT1a2淋巴血管空间侵犯阴性且切缘清晰的情况下，是否建议进行进一步治疗？\n\n<reference text>: # 5.6.2 Management of patients with pT1a1, LVSI $\\pm$ and pT1a2 LVSI-negative, with clear margins In patients with tumor stage pT1a1 regardless of LVSI status and pT1a2 LVSI negative with clear margins in the hysterectomy specimen, no additional treatment is recommended.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于宫颈癌患者，若肿瘤分期为pT1a1，无论是否存在淋巴血管空间侵犯（LVSI），以及分期为pT1a2且淋巴血管空间侵犯为阴性且切缘清晰的情况下，并不建议进行进一步的治疗。这意味着，手术切除后的这些早期宫颈癌患者在上述特定情况下无需接受额外的治疗。"
}